Key clinical point: Genetic testing may help identify the etiology of neuropathy in patients even with no family history.
Major finding: Next-generation sequencing demonstrated that 19% of patients with neuropathy tested positive for a pathogenic mutation.
Study details: The findings are based on next-generation genetic sequencing of 85 patients at the University of Pittsburgh Medical Center’s Neuromuscular Clinic.
Disclosures: No external funding was noted, and the authors had no disclosures.
Zivkovic S et al. AANEM 2019. Abstract 160. Targeted genetic testing in the evaluation of neuropathy.